Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics

BACKGROUND AND OBJECTIVE: Schizophrenia and Alzheimer’s disease are characterised by abnormalities in glutamatergic pathways related to N-methyl-d-aspartate receptor hypofunction. Glycine is an N-methyl-d-aspartate receptor co-agonist; inhibition of glycine transporter 1 may improve N-methyl-d-aspar...

Descripción completa

Detalles Bibliográficos
Autores principales: Moschetti, Viktoria, Schlecker, Christina, Wind, Sven, Goetz, Sophia, Schmitt, Holger, Schultz, Armin, Liesenfeld, Karl-Heinz, Wunderlich, Glen, Desch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061410/
https://www.ncbi.nlm.nih.gov/pubmed/29846887
http://dx.doi.org/10.1007/s40261-018-0660-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061410/
https://www.ncbi.nlm.nih.gov/pubmed/29846887
http://dx.doi.org/10.1007/s40261-018-0660-2

Ejemplares similares